NBIX · Neurocrine Biosciences Inc
$180.79
-2.04 (-1.12%)
At close · Jul 29
Earnings today
Market Cap
$18.18B
Shares
100.55M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-25 | 201,605 | $166.06 | $33,478,526 |
| 2026-06-15 | 299 | $159.76 | $47,768 |
| 2026-06-08 | 246 | $163.88 | $40,314 |
| 2026-06-04 | 4,834 | $165.11 | $798,142 |
| 2026-06-02 | 28,872 | $161.00 | $4,648,392 |
| 2026-05-21 | 37,328 | $154.67 | $5,773,522 |
| 2026-05-20 | 228,282 | $154.36 | $35,237,610 |
| 2026-05-18 | 3,034 | $158.42 | $480,646 |
| 2026-05-15 | 3,224 | $159.05 | $512,777 |
| 2026-05-14 | 30,536 | $161.32 | $4,926,068 |
| 2026-05-13 | 28,599 | $155.80 | $4,455,724 |
| 2026-05-11 | 256 | $152.25 | $38,976 |
| 2026-05-07 | 11,883 | $147.02 | $1,747,039 |
Showing 1–13 of 13 settlements
Key facts
CIK
914475
CUSIP
64125C109
13F (30d)
255 filings
228 filers
Visit website
Investor relations